Dear Democracy Now! Visitor: We are an independent, ad-free daily news program that serves millions of viewers and listeners each month. Our show is special because we make it our priority to go where the silence is. We put a spotlight on corporate and government abuses of power and lift up the stories of ordinary people working to make change in extraordinary times. We do all of this with just a fraction of the budget and staff of a commercial news show. We do it without ads, corporate sponsorship or government funding. How is this possible? Only with your support. If everyone who visited our website in the next week donated just $15, we would cover all of our operating costs for the year. We can't do it without you. Please donate today. It takes just a couple of minutes to do your part to make sure Democracy Now! is there for you and everybody else.

Your Donation: $
Thursday, August 27, 1998 FULL SHOW | HEADLINES | NEXT: Sudan Sues the United States
1998-08-27

Empta

download:   Get CD/DVD More Formats
This is viewer supported news

The United States State Department has, at different times, offered several reasons for bombing the El Shifa pharmaceutical plant near Khartoum, Sudan: that it was linked to Saudi dissident Osama ben Laden, that U.S. intelligence had secretly found traces of a chemical component Empta that can only be used to make VX nerve gas, that the factory was producing chemical weapons for the Iraqi government.

But now it’s clear that nothing’s clear: experts disagree with the government’s contentions about Empta. A spokesperson for the Organization for the Prohibition of Chemical Weapons in The Hague says that EMPTA does have legitimate commercial uses. In the strangest twist yet, the New York Times yesterday implied that the U.S. had bombed the factory for humanitarian purposes! The report said, "a military complex on the southern outskirts of the city, not the plant that was attacked, was the most likely place for the production." The story went on to quote American diplomats who said, "they believed that the factory had been chosen as a target because it could be more precisely hit than the military plant and without running the risk of deadly vapors."

But the Sudanese government says the factory produced nearly half of the country’s medicine, including anti-malarial drugs.

Guest:

  • Amy Smithson, a Senior Associate at the Henry L. Stimson Center based in Washington, D.C.

Creative Commons License The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

This is viewer supported news